Región Metropolitana de Santiago
Este organismo compró $88.391.088.811 en 61.085 órdenes de compra , sobre todo en Salud, servicios sanitarios y alimentación / Medicina y servicios de salud / Evaluaciones de salud individuales y le compró principalmente a Instituto Medico Donoso Ltda..
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $4447,5 M |
| 2025 | $8368,1 M |
| 2024 | $9689,5 M |
| 2023 | $6300,7 M |
| 2022 | $6271,1 M |
| 2021 | $4443,4 M |
| 2020 | $3860,8 M |
| 2019 | $4174,1 M |
| 2018 | $4599 M |
| 2017 | $5174,4 M |
| 2016 | $5596,7 M |
| 2015 | $3986,9 M |
| 2014 | $4069,9 M |
| 2013 | $2736,1 M |
| 2012 | $1929 M |
| 2011 | $3217,6 M |
| 2010 | $2853,6 M |
| 2009 | $2400,6 M |
| 2008 | $2185,5 M |
| 2007 | $1852,2 M |
| 2006 | $234,2 M |
Gasto en remedios comprados fuera de CENABAST cada segundo semestre, y la proyección H2-2026 (estacional). En verde, el sobreprecio evitable si se comprara vía CENABAST (~27%, conservador).
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 1973-2986-SE20 | 31-12-2020 | Farmaceutica Insuval S.A. | Recepcion Conforme | $278.282 |
| 1973-2987-CM20 | 31-12-2020 | Nemo Chile S.A. | Recepcion Conforme | $361.417 |
| 1973-2988-CM20 | 31-12-2020 | Empresa Comercializadora Luis Valdes Lyon SpA | Recepcion Conforme | $87.409 |
| 1973-2989-SE20 | 31-12-2020 | Megalabs Chile S.A. | Recepcion Conforme | $1.558.900 |
| 1973-2990-SE20 | 31-12-2020 | Carpedent SpA | Recepcion Conforme | $73.780 |
| 1973-2991-SE20 | 31-12-2020 | Amilab Articulos Medicos y de Laboratorios Limitada | Recepcion Conforme | $2.507.616 |
| 1973-2992-SE20 | 31-12-2020 | Laboratorio Chile S.A. | Recepcion Conforme | $174.637 |
| 1973-2993-SE20 | 31-12-2020 | Laboratorio Chile S.A. | Recepcion Conforme | $133.280 |
| 1973-2994-SE20 | 31-12-2020 | Novo Nordisk Farmaceutica Limitada | Recepcion Conforme | $1.706.460 |
| 1973-2995-SE20 | 31-12-2020 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $458.388 |
| 1973-2996-SE20 | 31-12-2020 | Importadora y Distribuidora Arquimed Ltda. | Recepcion Conforme | $3.660.440 |
| 1973-2997-SE20 | 31-12-2020 | Servicios y Mantenciones Msoluciones Limitada | Recepcion Conforme | $9.630.274 |
| 1973-2998-CM20 | 31-12-2020 | Esso Chile Petrolera Limitada | Recepcion Conforme | $19.251 |
| 1973-2947-SE20 | 30-12-2020 | Opko Chile S.A. | Recepcion Conforme | $220.001 |
| 1973-2965-SE20 | 30-12-2020 | Johnson y Johnson de Chile S.A. | Aceptada | $62.832 |
| 1973-2966-SE20 | 30-12-2020 | Ethon Pharmaceuticals Ltda. | Recepcion Conforme | $21.707 |
| 1973-2967-SE20 | 30-12-2020 | Winpharm SpA | Recepcion Conforme | $114.240 |
| 1973-2968-SE20 | 30-12-2020 | Drogueria Global Pharma SpA | Recepcion Conforme | $26.180 |
| 1973-2974-SE20 | 30-12-2020 | Patricio Ivan Pena Suazo | Enviada a proveedor | $168.067 |
| 1973-2975-SE20 | 30-12-2020 | Laboratorio Silesia S.A. | Recepcion Conforme | $278.460 |
| 1973-2976-SE20 | 30-12-2020 | Ascend Laboratories SpA | Recepcion Conforme | $2.034.900 |
| 1973-2977-SE20 | 30-12-2020 | Winpharm SpA | Recepcion Conforme | $166.005 |
| 1973-2978-SE20 | 30-12-2020 | Ascend Laboratories SpA | Recepcion Conforme | $88.060 |
| 1973-2979-SE20 | 30-12-2020 | Abbott Laboratories de Chile Ltda. | Recepcion Conforme | $2.284.800 |
| 1973-2980-SE20 | 30-12-2020 | Valtek S.A. | Recepcion Conforme | $248.234 |
| 1973-2981-SE20 | 30-12-2020 | Drogueria Global Pharma SpA | Enviada a proveedor | $285.743 |
| 1973-2982-SE20 | 30-12-2020 | Laboratorio Silesia S.A. | Recepcion Conforme | $157.080 |
| 1973-2983-SE20 | 30-12-2020 | Novartis Chile S.A. | Recepcion Conforme | $1.566.073 |
| 1973-2984-SE20 | 30-12-2020 | Importadora y Comercializadora Re-Med SpA | Recepcion Conforme | $65.450 |
| 1973-2985-AG20 | 30-12-2020 | Laboratorio Sanderson S.A. | Recepcion Conforme | $332.367 |
